ClinicalThought

Share

Program Content

Activities

  • Hemophilia A Management
    What You Need to Know About Evolving Options for the Treatment of Hemophilia A
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 14, 2020

    Expires: October 13, 2021

  • Hemophilia at ASH 2020
    My Thoughts on Hemophilia Studies From ASH 2020 With Direct Impact on Patient Care
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 18, 2020

    Expires: December 17, 2021

  • Hemophilia A: FAQ
    Experts Answer Frequently Asked Questions on Hemophilia A Management
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 16, 2021

    Expires: February 15, 2022

Faculty

cover img faculity

Michael Callaghan, MD

Associate Professor
Department of Hematology
Wayne State University
Hematologist
Division of Hematology/Oncology
Childrens Hospital of Michigan
Detroit, Michigan

cover img faculity

Stacy E. Croteau, MD, MMS

Assistant Professor of Pediatrics
Department of Hematology
Boston Childrens Hospital
Harvard Medical School
Boston, Massachusetts

cover img faculity

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics
Division of Hematology
McGovern Medical School
Director
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas

cover img faculity

Rebecca Kruse-Jarres, MD, MPH

Professor
Department of Medicine
University of Washington
Executive/Medical Director
Washington Institute for Coagulation
Seattle, Washington

cover img faculity

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Supporters

Genentech, a member of the Roche Group

Sanofi Genzyme Corp

Takeda Pharmaceutical Co Ltd